MOVELARGE

Corvex, Inc.

HealthcareMedical - Devices
$22.97
$0.02(+6.93%)
52W$4.67
$34.87
Updated Jun 22, 02:00 AM
RSI62
RS Rating96/99
Beta1.37
Volatility145%
F-Score2/9
Mkt Cap$37.4B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Corvex, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 96), indicating clear outperformance against the broad market. Earnings contraction of 215% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
96
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.37
vs S&P 500
ABOVE MKT
52W Position
61%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$18.08
50 SMA > 100 SMA$15.74
100 SMA > 150 SMA$13.58
150 SMA > 200 SMA$11.94

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$20.21+13.68%ABOVE
50 SMA$18.08+27.05%ABOVE
100 SMA$15.74+45.94%ABOVE
150 SMA$13.58+69.19%ABOVE
200 SMA$11.94+92.35%ABOVE

Price Performance

1D+6.9%
1W+24.3%
1M+22.2%
3M+49.3%
6M+198.0%
YTD+156.6%
1Y+192.6%
3Y-47.5%
52-Week Trading Range61% from low
$22.97
52W Low$4.67
52W High$34.87

Technical Indicators

RSI (14)BULLISH
62.1
305070
Setup ScoreCOOL
3/10
Base depth: 75.9%

Risk Profile

Beta
1.37
52W Vol
145%
ATR
$1.93
Max DD (1Y)
-56%

Volume Analysis

Today
28.3K
50D Avg
60.3K
Vol Ratio
0.47x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-339%
$-0.41
Q3'25+53%
$-0.05
Q4'25-6127%
$-4.77
Q1'26-215%
$-2.30
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:+100.82%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-6.46%

Stock Price CAGR

10 Years:-31.50%
5 Years:-50.01%
3 Years:-47.53%
1 Year:+192.60%

Return on Equity

10Y Avg:-369.3%
5Y Avg:-445.7%
3Y Avg:-632.3%
Last Year:-12.7%

Key Metrics

Market Cap$37.4B
Gross Margin-4.2%
Net Margin-42.2%
Piotroski F-Score2/9

Frequently Asked Questions

Is MOVE in an uptrend right now?

MOVE has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, MOVE is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is MOVE overbought or oversold?

MOVE's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.

Is MOVE outperforming the market?

MOVE has a Relative Strength (RS) Rating of 96 out of 99. Yes, MOVE is a market leader, outperforming 96% of all stocks over the past 12 months.

Where is MOVE in its 52-week range?

MOVE is trading at $22.97, which is 66% of its 52-week high ($34.87) and 61% above its 52-week low ($4.67).

How volatile is MOVE?

MOVE has a Beta of 1.37 and 52-week volatility of 145%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.